TREM1 mRNA Expression in Leukocytes and Cognitive Function in Japanese Patients with Alzheimer’s Disease

Journal of Alzheimer's Disease - Tập 64 Số 4 - Trang 1275-1284 - 2018
Tomoko Sao1, Yuta Yoshino1, Kiyohiro Yamazaki1, Yuki Ozaki1, Yoko Mori1, Shinichiro Ochi1, Taku Yoshida1, Takaaki Mori1, Jun‐ichi Iga1, Shuichi Ueno1
1Department of Neuropsychiatry, Molecules and Function, Ehime University Graduate School of Medicine, Shitsukawa, Toon, Ehime, Japan

Tóm tắt

Background: Triggering receptor expressed on myeloid cells 2 (TREM2) activates the innate immune system, promotes phagocytosis by microglia, and is associated with Alzheimer’s disease (AD). The possible role of a related molecule, TREM1, in AD remains unknown. Objective: We investigated a possible role for TREM1 in AD by determining the gene expression and methylation levels of TREM1 in leukocytes from AD patients. Methods: Fifty patients with AD and 50 age-matched healthy controls were enrolled. AD patients underwent a battery of neuropsychiatric tests. Peripheral blood samples were obtained from each participant, RNA and DNA were extracted, and samples were assessed for TREM1 mRNA expression and methylation rates at three CpG sites in the TREM1 promoter. Results: TREM1 mRNA expression levels in AD patients were significantly higher than those in controls ( p = 0.008). TREM1 mRNA expression levels were not correlated with sex, age, duration of illness, APOE genotype, donepezil treatment, or scores of most neuropsychiatric tests. TREM1 mRNA expression levels in AD patients were correlated with the total score of the Montgomery-Åsberg Depression Rating Scale ( p = 0.047, r = – 0.344). Methylation rates at the three CpG sites were significantly lower in AD patients than in controls. We also found a significant correlation between TREM1 mRNA expression and TREM1 DNA methylation rates ( p < 0.001). Conclusion: TREM1 may be associated with the immune responses in AD, and along with hypomethylation at CpG sites in the TREM1 promoter, may become part of a biomarker panel for AD pathogenesis.

Từ khóa


Tài liệu tham khảo

Guerreiro R, 2013, N Engl J Med, 369, 1569

10.1083/jcb.200808080

10.1056/NEJMoa1211103

10.1111/j.1471-4159.2009.06042.x

10.1016/j.cell.2015.01.049

10.1111/bpa.12190

10.1002/ana.24337

10.1371/journal.pone.0142360

10.1038/nn.4126

10.1189/jlb.0312145

10.1186/s13024-017-0197-5

10.3390/ijms161125983

10.1016/j.gene.2017.09.006

10.1159/000447324

10.1111/pcn.12618

10.3233/JAD-160430

10.1111/pcn.12462

10.3233/JAD-161195

10.3233/JAD-161211

10.1002/ajmg.b.20142

10.1016/j.jpsychires.2017.04.003

10.1016/0022-3956(75)90026-6

10.1176/ajp.141.11.1356

10.1192/bjp.134.4.382

10.1192/bjp.140.6.566

10.1212/WNL.44.12.2308

10.1158/0008-5472.CAN-04-0496

10.1186/1471-2172-8-20

10.1002/hup.2381

10.1016/j.jpsychires.2015.03.004

10.1038/bmt.2012.244

10.1016/j.conb.2015.10.004

10.1038/ncomms13151

10.1002/oby.21714

Xu W, 2015, J Neurol Neurosurg Psychiatry, 86, 1299

10.1016/j.bbi.2011.03.006

10.1016/j.jagp.2016.07.017

10.3233/JAD-151129

10.3233/JAD-161061

10.3233/JAD-2006-9406

10.1073/pnas.0500398102

10.1007/s00439-007-0430-3

10.1016/S0140-6736(13)62674-4

10.3389/fgene.2013.00132

10.1165/rcmb.2014-0103OC

10.18632/oncotarget.7862

10.1016/j.nbd.2016.07.007

10.1080/15592294.2014.1003743

10.1038/tp.2013.111

10.1186/gb-2012-13-6-r43

10.1136/bmjopen-2015-010314

Thông tin
Thông tin xuất bản

Journal of Alzheimer's Disease

Tập 64 Số 4

1275-1284

Thông tin tác giả